Trials / Completed
CompletedNCT00126165
Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer
A Phase I/II Study of Escalated-dose Short-course Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Alberta Health services · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is aimed at providing further clinical evidence to support or refute the current understanding of biological sensitivity of prostate cancer to fractionated radiotherapy. Determining the morbidity and cancer control provided by a 4-week course of treatment will greatly influence future radiotherapy services for patients with localized prostate cancer.
Detailed description
This study is aimed at providing further clinical evidence to support or refute the current understanding of biological sensitivity of prostate cancer to fractionated radiotherapy. Determining the morbidity and cancer control provided by a 4-week course of treatment will greatly influence future radiotherapy services for patients with localized prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | radiotherapy |
Timeline
- Start date
- 2004-09-01
- Completion
- 2011-08-01
- First posted
- 2005-08-03
- Last updated
- 2012-01-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00126165. Inclusion in this directory is not an endorsement.